Stay updated with breaking news from Patrick Serruys. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Abbott's landmark LIFE-BTK randomized clinical trial met its primary safety and effectiveness endpoints, demonstrating that Esprit BTK offers significant advancements in opening and keeping blocked arteries below-the-knee open compared to the standard of care, balloon angioplasty
New clinical data support use of lesion-specific FFRCT for diagnosis and treatment of patients with coronary artery disease
FAME 3 was negative, rendering this prespecified analysis hypothesis-generating, but the findings make sense to FFR users.
Neither PCI nor CABG is going away, and both play important roles in coronary revascularization, says surgeon Mario Gaudino.
A low pullback pressure gradient indicates diffuse coronary disease that probably won’t respond well to stenting.